Showing results (2241-2250 of 2,272) with videos related to

Sort By:
Pageof 228
Pulmonology|May 28, 2024
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational studyL Rinaldi, M Lugarà, V Simeon, et al.
The Lancet. Psychiatry|December 10, 2023
Psychopharmacology in children and adolescents: unmet needs and opportunitiesSamuele Cortese, Diane Purper-Ouakil, Alan Apter, et al.
Obesity Surgery|September 25, 2024
Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)Maurizio De Luca, Scott Shikora, Dan Eisenberg, et al.
Frontiers in Pharmacology|April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment ResponseAntonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Medicine|March 11, 2020
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory OutcomesAntonio Vitale, Giulio Cavalli, Piero Ruscitti, et al.
Neuron|November 20, 2018
Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical MalformationsRatna Tripathy, Ines Leca, Tessa van Dijk, et al.
Clinical Rheumatology|May 18, 2018
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyJurgen Sota, Antonio Vitale, Antonella Insalaco, et al.
Genetics in Medicine Open|April 22, 2026
Telethon Undiagnosed Disease Program: Structured approach to solving rare childhood-onset genetic diseasesAnnalaura Torella, Manuela Morleo, Carmine Spampanato, et al.
Pageof 228